During the COVID-19 period, special attention and medical care should be provided to patients with gastrointestinal malignancies, especially the elderly with elevated expression of ACE-2 and TMPRSS2, and severe forms of COVID-19 should be provided. This evidence concerns the gene ACE2 and COVID-19.